Development of myeloid-derived suppressor cells as a the

Project: Research project

Project Details

Description

Development of myeloid-derived suppressor cells as a therpeutic
StatusFinished
Effective start/end date5/27/114/5/13

Funding

  • Boehringer-Ingelheim Pharmaceuticals

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.